SI3600363T1 - Sestavki, ki vsebujejo bakterijske seve - Google Patents
Sestavki, ki vsebujejo bakterijske seveInfo
- Publication number
- SI3600363T1 SI3600363T1 SI201830161T SI201830161T SI3600363T1 SI 3600363 T1 SI3600363 T1 SI 3600363T1 SI 201830161 T SI201830161 T SI 201830161T SI 201830161 T SI201830161 T SI 201830161T SI 3600363 T1 SI3600363 T1 SI 3600363T1
- Authority
- SI
- Slovenia
- Prior art keywords
- compositions
- bacterial strains
- strains
- bacterial
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Physiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1709465.7A GB201709465D0 (en) | 2017-06-14 | 2017-06-14 | Compositions comprising bacterial strains |
GBGB1709526.6A GB201709526D0 (en) | 2017-06-15 | 2017-06-15 | Compositions comprising bacterial strains |
GBGB1805989.9A GB201805989D0 (en) | 2018-04-11 | 2018-04-11 | Compositions comprising bacterial strains |
GBGB1805991.5A GB201805991D0 (en) | 2018-04-11 | 2018-04-11 | Compositions comprising bacterial strains |
GBGB1805990.7A GB201805990D0 (en) | 2018-04-11 | 2018-04-11 | Compostions comprising bacterial strains |
GBGB1806780.1A GB201806780D0 (en) | 2018-04-25 | 2018-04-25 | Compositions comprising bacterial strains |
GBGB1806779.3A GB201806779D0 (en) | 2018-04-25 | 2018-04-25 | Compositions comprising bacterial strains |
PCT/EP2018/065809 WO2018229189A1 (en) | 2017-06-14 | 2018-06-14 | Compositions comprising bacterial strains |
EP18731819.1A EP3600363B1 (en) | 2017-06-14 | 2018-06-14 | Compositions comprising bacterial strains |
Publications (1)
Publication Number | Publication Date |
---|---|
SI3600363T1 true SI3600363T1 (sl) | 2021-01-29 |
Family
ID=62631106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201830161T SI3600363T1 (sl) | 2017-06-14 | 2018-06-14 | Sestavki, ki vsebujejo bakterijske seve |
Country Status (22)
Country | Link |
---|---|
EP (2) | EP3600363B1 (sl) |
JP (2) | JP6840272B2 (sl) |
KR (1) | KR102521444B1 (sl) |
CN (2) | CN111107859B (sl) |
AU (2) | AU2018285445B2 (sl) |
BR (1) | BR112019026477A2 (sl) |
CA (1) | CA3066189A1 (sl) |
CY (1) | CY1123857T1 (sl) |
DK (1) | DK3600363T3 (sl) |
ES (1) | ES2855701T3 (sl) |
HR (1) | HRP20210205T1 (sl) |
HU (1) | HUE053488T2 (sl) |
IL (2) | IL283973B (sl) |
LT (1) | LT3600363T (sl) |
MD (1) | MD3600363T2 (sl) |
PL (1) | PL3600363T3 (sl) |
PT (1) | PT3600363T (sl) |
RS (1) | RS61367B1 (sl) |
SG (1) | SG11201912105PA (sl) |
SI (1) | SI3600363T1 (sl) |
TW (1) | TWI767013B (sl) |
WO (1) | WO2018229189A1 (sl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3804737T3 (da) | 2017-06-14 | 2022-07-25 | 4D Pharma Res Ltd | Sammensætninger omfattende bakteriestammer |
BR112019026477A2 (pt) * | 2017-06-14 | 2020-07-14 | 4D Pharma Research Limited | composições compreendendo cepas bacterianas |
MD3743086T2 (ro) * | 2018-05-11 | 2022-12-31 | 4D Pharma Res Limited | Compoziții cuprizând tulpini bacteriene |
CN112410242A (zh) * | 2020-08-25 | 2021-02-26 | 上海市第十人民医院 | 一株分离自直肠癌肿瘤组织的狄氏副拟杆菌株及其应用 |
WO2023001368A1 (en) * | 2021-07-20 | 2023-01-26 | Université Catholique de Louvain | Prevention and/or treatment of reward dysregulation disorders |
CA3226267A1 (en) * | 2021-07-20 | 2023-01-26 | Amandine EVERARD | Prevention and/or treatment of reward dysregulation disorders |
CN113750121A (zh) * | 2021-08-20 | 2021-12-07 | 上海交通大学医学院附属瑞金医院 | 一种狄氏副拟杆菌在制备阿尔茨海默病药物制剂中的应用 |
WO2023164591A2 (en) * | 2022-02-23 | 2023-08-31 | Metagenomi, Inc. | Systems and methods for transposing cargo nucleotide sequences |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPQ899700A0 (en) * | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
GB0127916D0 (en) | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
US20040005304A1 (en) * | 2002-07-08 | 2004-01-08 | Mak Wood, Inc. | Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions |
EP3954715A3 (en) | 2006-10-27 | 2022-05-04 | Capsugel Belgium NV | Hydroxypropyl methyl cellulose hard capsules and process of manufacture |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
CN103857402A (zh) * | 2011-10-11 | 2014-06-11 | 阿基姆医药公司 | 包括厌氧培养的人类肠道微生物群的组合物 |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
CN104546934B (zh) * | 2014-09-30 | 2019-04-09 | 深圳华大基因科技有限公司 | 粪副拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用 |
SE1550189A1 (en) * | 2015-02-19 | 2016-08-20 | Achim Biotherapeutics Ab | Therapeutic and prophylactic composition produced by microbiota |
EP3636272A1 (en) * | 2015-06-15 | 2020-04-15 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
MA41060B1 (fr) * | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
IL298281A (en) * | 2015-11-03 | 2023-01-01 | Brigham & Womens Hospital Inc | Medical microbiota for the treatment and/or prevention of food allergy |
EP3558329B1 (en) * | 2016-12-20 | 2024-01-31 | The Regents of The University of California | Compositions and methods for inhibiting seizures |
BR112019026477A2 (pt) * | 2017-06-14 | 2020-07-14 | 4D Pharma Research Limited | composições compreendendo cepas bacterianas |
US20210364526A1 (en) * | 2018-05-23 | 2021-11-25 | The Regents Of The University Of California | Methods of selecting subjects for treatment with metabolomic modulators |
-
2018
- 2018-06-14 BR BR112019026477-9A patent/BR112019026477A2/pt unknown
- 2018-06-14 DK DK18731819.1T patent/DK3600363T3/da active
- 2018-06-14 SI SI201830161T patent/SI3600363T1/sl unknown
- 2018-06-14 ES ES18731819T patent/ES2855701T3/es active Active
- 2018-06-14 HU HUE18731819A patent/HUE053488T2/hu unknown
- 2018-06-14 EP EP18731819.1A patent/EP3600363B1/en active Active
- 2018-06-14 KR KR1020197037443A patent/KR102521444B1/ko active IP Right Grant
- 2018-06-14 EP EP20210763.7A patent/EP3858367A1/en active Pending
- 2018-06-14 CN CN201880039720.5A patent/CN111107859B/zh active Active
- 2018-06-14 MD MDE20200143T patent/MD3600363T2/ro unknown
- 2018-06-14 SG SG11201912105PA patent/SG11201912105PA/en unknown
- 2018-06-14 RS RS20210088A patent/RS61367B1/sr unknown
- 2018-06-14 PL PL18731819T patent/PL3600363T3/pl unknown
- 2018-06-14 AU AU2018285445A patent/AU2018285445B2/en active Active
- 2018-06-14 CA CA3066189A patent/CA3066189A1/en not_active Abandoned
- 2018-06-14 CN CN202210381608.8A patent/CN115813955A/zh active Pending
- 2018-06-14 TW TW107120603A patent/TWI767013B/zh active
- 2018-06-14 JP JP2019567619A patent/JP6840272B2/ja active Active
- 2018-06-14 WO PCT/EP2018/065809 patent/WO2018229189A1/en active Search and Examination
- 2018-06-14 PT PT187318191T patent/PT3600363T/pt unknown
- 2018-06-14 IL IL283973A patent/IL283973B/en unknown
- 2018-06-14 LT LTEP18731819.1T patent/LT3600363T/lt unknown
-
2019
- 2019-12-03 IL IL271152A patent/IL271152B/en active IP Right Grant
-
2020
- 2020-06-26 AU AU2020204265A patent/AU2020204265A1/en not_active Abandoned
-
2021
- 2021-02-05 HR HRP20210205TT patent/HRP20210205T1/hr unknown
- 2021-02-15 CY CY20211100127T patent/CY1123857T1/el unknown
- 2021-02-16 JP JP2021022774A patent/JP2021080269A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL271319A (en) | Preparations containing bacterial strains | |
IL283973A (en) | Preparations containing bacterial strains | |
PT3638271T (pt) | Composições contendo estirpes bacterianas | |
PL3630136T3 (pl) | Kompozycje zawierające szczepy bakteryjne | |
GB201708182D0 (en) | Compositions comprising bacterial strains | |
IL272491A (en) | Preparations containing bacterial strains | |
GB201718551D0 (en) | Compositions comprising bacterial strains | |
GB201714305D0 (en) | Compositions comprising bacterial strains | |
GB201714309D0 (en) | Compositions comprising bacterial strains | |
GB201714298D0 (en) | Compositions comprising bacterial strains | |
GB201712857D0 (en) | Compositions comprising bacterial strains | |
GB201712851D0 (en) | Compositions comprising bacterial strains | |
GB201709526D0 (en) | Compositions comprising bacterial strains | |
GB201709534D0 (en) | Compositions comprising bacterial strains | |
GB201709533D0 (en) | Compositions comprising bacterial strains | |
GB201709465D0 (en) | Compositions comprising bacterial strains | |
GB201709468D0 (en) | Compositions comprising bacterial strains | |
GB201709466D0 (en) | Compositions comprising bacterial strains | |
GB201708176D0 (en) | Compositions comprising bacterial strains | |
GB201703552D0 (en) | Compositions comprising bacterial strains | |
GB201703548D0 (en) | Compositions comprising bacterial strains | |
GB201604920D0 (en) | Compositions comprising bacterial strains | |
GB201604566D0 (en) | Compositions comprising bacterial strains | |
GB201603786D0 (en) | Compositions comprising bacterial strains | |
GB201603817D0 (en) | Compositions comprising bacterial strains |